For Supplements

Compliant AI ads for supplements.

Brands stop fighting Meta review. Hero stacks ship the day formulas drop.

Built for
DTC supplement brands launching new SKUs and stacks
Trigger
Meta disabling another ad set for claims
Three Coinis-generated supplement ads on a wood table Ad preview

Supplements

Sponsored

The morning stack people swear by.

Shop the stack

The problem

Compliance kills creative. Subscribers churn at month two.

Three patterns kill supplement ads. Coinis fixes each.

  • 01

    Meta disables half your supplement ads.

  • 02

    Stock white pill bottles look generic.

  • 03

    Compliance edits delay every launch by weeks.

Why ads fail in supplements

Supplement ads fail two ways. They overpromise and trip Meta health review. Or they hedge and sound like every other vitamin brand. Coinis trains on your label, your testing data, your customer language. Ships variants that pass review on the first try and still sell. Subscription LTV climbs because the creative attracts the right buyer.

Creative rules we keep

  • Ingredient story beats benefit promise on Meta health review.
  • Real-customer routine reels outperform stock supplement shots.
  • Subscribe-to-save in the first frame lifts subscription rate by 22 percent.

Ad formats

Three formats that move supplement subscriptions.

Every format below ships from one link. No designer. No shoot day.

01

Stack hero reel

Vertical stack reveal with motion clears Meta and converts.

02

Ingredient story carousel

Sourced ingredients build trust without claim risk.

03

Subscribe lead form

Compliant lead form converts pre-qualified buyers.

Creative angles we test for you

  • ingredient explainer
  • compliant outcome story
  • subscription-saver offer

Real examples

Three ads Coinis would build for a supplements brand today.

Hook. Visual. CTA. Built from one prompt. Ready for Meta in minutes.

Supplements ad creative example 1: The morning stack people swear by.

The morning stack people swear by.

Example 1

Visual brief

Bottles arranged by routine order, soft daylight.

CTA Shop the stack
Supplements ad creative example 2: Five ingredients. No filler.

Five ingredients. No filler.

Example 2

Visual brief

Top-down ingredient grid, gradient label pills.

CTA See the formula
Supplements ad creative example 3: Subscribe. Save 20%. Skip anytime.

Subscribe. Save 20%. Skip anytime.

Example 3

Visual brief

Calendar grid with subscription pills.

CTA Start subscription

Metrics we move

  • ROAS
  • subscribe rate
  • Meta approval rate

How it works

From supplements link to live ad. Three steps.

No designer. No agency. No Ads Manager UI. Coinis runs the loop end to end.

  1. 1

    Paste your DTC URL.

    Coinis reads the label, the testing claims, the customer reviews. Pulls compliant frames automatically.

  2. 2

    Pick the buyer.

    First-time customer. Active subscriber. Cancellation save. Coinis builds creative tuned to each lifecycle stage.

  3. 3

    Run on Meta. Track LTV.

    Connect Recharge or Skio once. Coinis attributes subscription LTV by ad set, not just first order.

Questions supplements owners ask

Honest answers before you sign up.

Will my ads pass Meta review? +

Coinis filters disallowed claims before publish.

Can it support multi-SKU stacks? +

Yes. Coinis ties bundles to your catalog.

Can it ship a launch creative bank for a new SKU? +

Yes. Drop the new SKU page. Coinis ships a 12-variant launch bank inside an hour. Refresh prompts run nightly through the launch window.

Will my ads pass Meta's health and supplement review? +

Coinis pre-screens against Meta's prohibited claims, FTC substantiation, and FDA structure-function rules. First-pass approval rate runs above 92 percent.

Can it handle clinical-style messaging? +

Yes, when you have the data to back it. Coinis pulls citations from your study library and gates the language behind your evidence pack.

Coinis for Supplements

Compliant AI ads for supplements.

Stop dodging Meta review. Subscriptions start while the lab fills the next batch.